Home » Topics » Regulatory » EMA

EMA
RSS

COMP recommends orphan drug status for Nektar Therapeutics' lead oncology agent in ovarian cancer

July 19, 2011

BioAlliance gives update on Livatag and Clonidine Lauriad

July 14, 2011

Advanced Cell Technology's RPE cells gain E.U. orphan drug status in Stargardt's macular dystrophy

July 7, 2011

CHMP adopts positive opinion on new Kiovig indication in multifocal motor neuropathy

July 1, 2011

CHMP recommends approval of Eurartesim for malaria

June 30, 2011

EMA accepts tesamorelin MAA for review

June 29, 2011

Amgen obtains positive CHMP opinion on Vectibix after reexamination

June 29, 2011

CHMP adopts positive opinion on Buccolam

June 29, 2011

CHMP issues negative opinion on Bronchitol for cystic fibrosis

June 28, 2011

CHMP issues negative opinion on Glybera MAA

June 28, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...